Simulation of the oxidative metabolism of diclofenac by electrochemistry/(liquid chromatography/)mass spectrometry
- 9 January 2012
- journal article
- research article
- Published by Springer Nature in Analytical and Bioanalytical Chemistry
- Vol. 403 (2) , 345-354
Abstract
Diclofenac is a frequently prescribed drug for rheumatic diseases and muscle pain. In rare cases, it may be associated with a severe hepatotoxicity. In literature, it is discussed whether this toxicity is related to the oxidative phase I metabolism, resulting in electrophilic quinone imines, which can subsequently react with nucleophiles present in the liver in form of glutathione or proteins. In this work, electrochemistry coupled to mass spectrometry is used as a tool for the simulation of the oxidative pathway of diclofenac. Using this purely instrumental approach, diclofenac was oxidized in a thin layer cell equipped with a boron doped diamond working electrode. Sum formulae of generated oxidation products were calculated based on accurate mass measurements with deviations below 2 ppm. Quinone imines from diclofenac were detected using this approach. It could be shown for the first time that these quinone imines do not react with glutathione exclusively but also with larger molecules such as the model protein β-lactoglobulin A. A tryptic digest of the generated drug–protein adduct confirms that the protein is modified at the only free thiol-containing peptide. This simple and purely instrumental set-up offers the possibility of generating reactive metabolites of diclofenac and to assess their reactivity rapidly and easily.Keywords
This publication has 21 references indexed in Scilit:
- Separation and detection methods for covalent drug–protein adductsJournal of Chromatography B, 2003
- The Metabolism of Diclofenac - Enzymology and Toxicology PerspectivesCurrent Drug Metabolism, 2003
- Hepatic metabolism of diclofenac: role of human CYP in the minor oxidative pathwaysBiochemical Pharmacology, 1999
- Metabolic Activation of Diclofenac by Human Cytochrome P450 3A4: Role of 5-HydroxydiclofenacChemical Research in Toxicology, 1999
- Cytochrome P4502C11 Is a Target of Diclofenac Covalent Binding in RatsChemical Research in Toxicology, 1997
- Metabolic Activation and Immunochemical Localization of Liver Protein Adducts of the Nonsteroidal Anti-inflammatory Drug DiclofenacChemical Research in Toxicology, 1994
- Comparative cytotoxicity of non-steroidal anti-inflammatory drugs in primary cultures of rat hepatocytesToxicology in Vitro, 1994
- Diclofenac Covalent Protein Binding Is Dependent on Acyl Glucuronide Formation and Is Inversely Related to P450-Mediated Acute Cell Injury in Cultured Rat HepatocytesToxicology and Applied Pharmacology, 1993
- Immunochemical detection of liver protein adducts of the nonsteroidal antiinflammatory drug diclofenacChemical Research in Toxicology, 1993
- Biotransformation of Diclofenac Sodium (Voltaren®) in Animals and in Man.: II. Quantitative determination of the unchanged drug and principal phenolic metabolites, in urine and bileXenobiotica, 1979